Stockreport

FDA approves drug for loss of sexual desire in women [Reuters (UK)]

Palatin Technologies, Inc.  (PTN) 
NASDAQ:AMEX Investor Relations: palatin.com/investors/overview
PDF FDA approves drug for loss of sexual desire in women - Reuters 3 Min Read (Reuters) - The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceut [Read more]